To Increasing Research and Development in Gene and Cell Therapies to drive Epidermolysis Bullosa Market Growth
The Epidermolysis Bullosa Market is estimated to be valued at US$ 3813.38 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Epidermolysis bullosa (EB) refers to a group of rare genetic disorders that cause easy blistering of the skin and mucous membranes from minor...
0 Comments 0 Shares 1044 Views 0 Reviews
Sponsored